ADUS Earnings Prediction
The chart below shows how ADUS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ADUS sees a +4.00% change in stock price 10 days leading up to the earnings, and a +2.27% change 10 days following the report. On the earnings day itself, the stock moves by +0.75%. This data can give you a slight idea of what to expect for the next quarter's release.
ADUS Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
289.79M
7.04%
1.00%
Gross Margin
30.63%
-0.94%
-2.08%
Operating Margin
8.96%
1.36%
-1.75%
Net Margin
6.96%
22.32%
10.48%
EPS
1.10
15.79%
0.00%
No Data Available
ADUS Earnings Analysis
Addus HomeCare Corp. Corporation (ADUS.O) Earnings Conference Call
Positive
Q3 Revenue Increase: 1. Revenue Growth: Addus HomeCare reported total revenue of $289.8 million for Q3 2024, marking a 7% increase from $270.7 million in Q3 2023.
Earnings Per Share Rise: 2. Earnings Per Share Increase: The adjusted earnings per share rose to $1.30 in Q3 2024, a 13% increase compared to $1.15 in the same quarter last year.
Adjusted EBITDA Increase: 3. Adjusted EBITDA Growth: Adjusted EBITDA for Q3 2024 was $34.3 million, reflecting an 11% increase from $30.9 million in Q3 2023.
Cash Reserves for Acquisitions: 4. Strong Cash Position: As of the end of Q3 2024, Addus had approximately $223 million in cash on hand, providing financial flexibility for future acquisitions.
Personal Care Revenue Growth: 5. Same-Store Revenue Growth: The Personal Care segment achieved same-store revenue growth of 6.8% compared to Q3 2023, driven by favorable reimbursement trends.
Negative
Home Health Revenue Decline: 1. Decline in Home Health Revenue: Home Health segment same-store revenue decreased by 1.7% compared to the same quarter in 2023, primarily due to the implementation of a standardized intake and scheduling process.
Rising General & Administrative Expenses: 2. Increased G&A Expenses: Following the divestiture of New York operations, adjusted G&A expense percentage is expected to increase by approximately 60 basis points going forward, as New York revenues will no longer be included in financial results.
Margin Decline Analysis: 3. Margin Compression: Gross margin percentage declined to 31.8% from 32% in the third quarter of 2023, and also decreased sequentially from 32.5% in the second quarter of 2024, indicating ongoing margin pressures.
Medicaid Re-determination Effects: 4. Impact of Medicaid Re-determination: Same-store hours in the Personal Care segment increased by only 0.6% due to the Medicaid re-determination process, which has slowed the approval of new personal care clients.
Decreased EBITDA Margin: 5. Lower Adjusted EBITDA Margin: Adjusted EBITDA margin decreased to 11.8% from 12.3% in the second quarter of 2024, reflecting the impact of ongoing leverage from revenue growth and lower legal expenses.
ADUS FAQs
How does ADUS typically perform around its earnings report dates?
Is Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ADUS Earning Call Sentiment
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
ADUS.O
0.61%Positive
The earnings call summary indicates strong financial performance with revenue and EPS growth, a significant acquisition expected to enhance revenue, and a solid cash position. The Q&A section highlights management's confidence in growth and manageable wage inflation risks. Despite some concerns about acquisition risks and competitive pressures, the overall sentiment remains positive, especially with the anticipated revenue boost from the Gentiva acquisition and reimbursement rate increases. Given the small-cap nature of the company, a stock price increase of 2% to 8% is expected over the next two weeks.
